Optimer Pharmaceuticals, Inc. (OPTR): SMA50 at $12.99 vs. SMA200 at $11.41 (last close at $11.82). The company has no debt. MRQ operating cash flow at $50.68M, vs. MRQ operating expenses at $24.46M.
very simple, their product dif is just coming to market. the income is from partnering agreements. it will be a while before the contracting and sales force is able to generate any measureable income.